Test Price
2,800 AED✅ Home Collection Available
SGCD Gene Limb‑Girdle Muscular Dystrophy Type 2F Genetic Test in UAE | 2800 AED
Executive Summary & Core Metrics
🔬 Premium LGMD2F Genetic Profiling – Accuracy Guaranteed
- 99.9% Diagnostic Sensitivity – NGS of the entire SGCD coding region, validated under ISO 9001:2015 (Cert: INT/EGQ/2509DA/3139).
- VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection – Available daily 8 AM–11 PM.
- Post-Test Clinical Guidance – Complimentary tele‑consult with a consultant medical geneticist.
- Insurance & Billing – Direct verification via WhatsApp at +971 54 548 8731.
Test Overview & Methodology
Limb‑Girdle Muscular Dystrophy Type 2F (LGMD2F) is an autosomal recessive neuromuscular disorder caused by biallelic loss‑of‑function variants in the SGCD (δ‑sarcoglycan) gene. This NGS‑based assay interrogates all coding exons and flanking splice sites to provide definitive diagnosis, carrier detection, and family risk assessment – essential for proactive neuromuscular management.
| Feature | Our Test (SGCD NGS) | Closest Alternative (Sanger Sequencing) |
|---|---|---|
| Precision / Sensitivity | 99.9% clinical sensitivity; full gene coverage with uniform depth >100× | ~98% for targeted mutations; may miss large deletions/insertions |
| Methodology | Next-Generation Sequencing (Illumina® platform) + bioinformatic analysis per ACMG guidelines | Capillary electrophoresis, single‑exon approach |
| Turnaround Time | 3 – 4 weeks (standard) | 4 – 6 weeks |
| Sample Type | Whole Blood (EDTA), Extracted DNA, or Dried Blood Spot (FTA® card) | Blood or DNA only |
Physician Insight & Safety Protocols
Dr. Lina Osama Zaki Quteineh, Consultant Medical Genetics (DHA Registration ID: 9294403) explains:
“LGMD2F often presents with progressive pelvic‑shoulder weakness, calf hypertrophy, and elevated creatine kinase levels. The SGCD NGS test provides molecular confirmation that differentiates this subtype from other limb‑girdle muscular dystrophies and guides cardiac and respiratory surveillance. Genetic results must always be correlated with clinical findings and family history; self‑interpretation is strongly discouraged.”
🩺 Advisory: Medication Safety
- Do not discontinue any prescribed medication (e.g., corticosteroids, cardiac drugs) without your neurologist’s approval.
- Emergency red flags: If you experience sudden difficulty breathing, chest pain, or acute loss of ambulation, seek emergency care immediately. This test is not a substitute for acute medical evaluation.
🚫 Exclusion Criteria
- Active infection or recent vaccination within 2 weeks.
- Current use of anticoagulants (relative contraindication – discuss with our phlebotomist before home collection).
- Inability to provide informed consent (for minors, parental consent is required).
Patient FAQ & Clinical Guidance
1. What conditions does the SGCD gene test detect?
Answer: The SGCD gene NGS definitively identifies biallelic mutations causing autosomal recessive limb‑girdle muscular dystrophy type 2F, enabling accurate diagnosis and family planning.
2. Is the test available for children?
Answer: Yes, the test can be performed on minors with clinical symptoms or family history, following parental consent and a pre‑test genetic counseling session, in compliance with UAE health data regulations.
3. How long does it take to receive results?
Answer: Standard turnaround time is 3 to 4 weeks. Your DHA‑compliant digital report is delivered via encrypted email, followed by a physician‑led tele‑consultation to explain findings.
4. Can I collect the sample at home?
Answer: Yes, we offer VIP Mobile Phlebotomy and temperature‑controlled cold‑chain home collection daily from 8 AM to 11 PM for whole blood samples.
UAE Regulatory & Data Privacy Adherence
🔒 Data Privacy & Regulatory Compliance
This test is performed under the governance of:
- Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) – ensuring the confidentiality and security of your genetic information.
- Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields – governing electronic health records and telemedicine.
- Federal Decree-Law No. 4 of 2016 on Medical Liability – establishing the legal framework for clinical testing safety and patient consent.
All procedures adhere to DHA standards and international best practices.
Clinical & Logistical Metadata
| Test Name | SGCD Gene Limb‑Girdle Muscular Dystrophy Type 2F Genetic Test |
| Price (AED) | 2800 AED |
| Turnaround Time | 3 – 4 weeks (standard) |
| Sample Type / Matrix | Whole Blood (EDTA), Extracted DNA, or Dried Blood Spot (FTA® card) – VIP Mobile Phlebotomy available |
| Methodology Used | Next-Generation Sequencing (NGS) on Illumina® platform; bioinformatic analysis per ACMG guidelines |
| ICD-10-CM Code | G71.0 |
| LOINC Code | 95193-8 |
| DHA Facility License & Laboratory Address | License No. 1143, Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE – Operated by DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians